121 related articles for article (PubMed ID: 34561192)
1. Individuals' preference for financial over social incentives for medication adherence.
Jeminiwa R; Hohmann NS; Hastings TJ; Hansen R; Qian J; Garza KB
J Am Pharm Assoc (2003); 2022; 62(1):134-141.e1. PubMed ID: 34561192
[TBL] [Abstract][Full Text] [Related]
2. Perceived appropriateness of medication adherence incentives.
Hastings TJ; Hohmann NS; Jeminiwa R; Hansen RA; Qian J; Garza KB
J Manag Care Spec Pharm; 2021 Jun; 27(6):772-778. PubMed ID: 34057397
[No Abstract] [Full Text] [Related]
3. Patient preferences for medication adherence financial incentive structures: A discrete choice experiment.
Hohmann NS; Hastings TJ; Jeminiwa RN; Qian J; Hansen RA; Ngorsuraches S; Garza KB
Res Social Adm Pharm; 2021 Oct; 17(10):1800-1809. PubMed ID: 33608244
[TBL] [Abstract][Full Text] [Related]
4. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
[TBL] [Abstract][Full Text] [Related]
5. Low-Income Participants' Preference Between Financial Incentives for Behavioral Goals vs Weight Loss Targets and Associations With Behavioral Goal Adherence.
Adhiyaman A; Jay M; Chung UYR; Gronda AN; Tseng CH; Wylie-Rosett J; Wittleder S; Wali S; Ladapo JA; Orstad SL
Am J Health Promot; 2024 May; ():8901171241254366. PubMed ID: 38748662
[TBL] [Abstract][Full Text] [Related]
6. The role of behavioral economic incentive design and demographic characteristics in financial incentive-based approaches to changing health behaviors: a meta-analysis.
Haff N; Patel MS; Lim R; Zhu J; Troxel AB; Asch DA; Volpp KG
Am J Health Promot; 2015; 29(5):314-23. PubMed ID: 25928816
[TBL] [Abstract][Full Text] [Related]
7. Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.
Barankay I; Reese PP; Putt ME; Russell LB; Loewenstein G; Pagnotti D; Yan J; Zhu J; McGilloway R; Brennan T; Finnerty D; Hoffer K; Chadha S; Volpp KG
JAMA Netw Open; 2020 Oct; 3(10):e2019429. PubMed ID: 33034639
[TBL] [Abstract][Full Text] [Related]
8. Examination of the Link Between Medication Adherence and Use of Mail-Order Pharmacies in Chronic Disease States.
Fernandez EV; McDaniel JA; Carroll NV
J Manag Care Spec Pharm; 2016 Nov; 22(11):1247-1259. PubMed ID: 27783552
[TBL] [Abstract][Full Text] [Related]
9. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
[TBL] [Abstract][Full Text] [Related]
10. Combining zip code-based population data and pharmacy administrative claims data to create measures of social determinants of health.
Hunter BD; Brown-Gentry KD; Santilli MA; Prasla K
J Manag Care Spec Pharm; 2024 Apr; 30(4):364-375. PubMed ID: 38555626
[TBL] [Abstract][Full Text] [Related]
11. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of Financial Incentives for Health Behaviours: A Discrete Choice Experiment.
Giles EL; Becker F; Ternent L; Sniehotta FF; McColl E; Adams J
PLoS One; 2016; 11(6):e0157403. PubMed ID: 27314953
[TBL] [Abstract][Full Text] [Related]
13. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
[TBL] [Abstract][Full Text] [Related]
14. Access to multilingual prescription labels and verbal translation services in California.
Zargarzadeh AH; Law AV
Res Social Adm Pharm; 2011 Dec; 7(4):338-46. PubMed ID: 21272528
[TBL] [Abstract][Full Text] [Related]
15. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
[TBL] [Abstract][Full Text] [Related]
16. Pilot Study to Test the Effectiveness of Different Financial Incentives to Improve Medication Adherence.
Garza KB; Owensby JK; Braxton Lloyd K; Wood EA; Hansen RA
Ann Pharmacother; 2016 Jan; 50(1):32-8. PubMed ID: 26447193
[TBL] [Abstract][Full Text] [Related]
17. Offering financial incentives to increase adherence to antipsychotic medication: the clinician experience.
Highton-Williamson E; Barnicot K; Kareem T; Priebe S
J Clin Psychopharmacol; 2015 Apr; 35(2):120-7. PubMed ID: 25692797
[TBL] [Abstract][Full Text] [Related]
18. Geosocial Factors Associated With Adherence to Statin Medications.
Erickson SR; Bravo M; Tootoo J
Ann Pharmacother; 2020 Dec; 54(12):1194-1202. PubMed ID: 32522004
[TBL] [Abstract][Full Text] [Related]
19. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
[TBL] [Abstract][Full Text] [Related]
20. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).
El-Sadr WM; Donnell D; Beauchamp G; Hall HI; Torian LV; Zingman B; Lum G; Kharfen M; Elion R; Leider J; Gordin FM; Elharrar V; Burns D; Zerbe A; Gamble T; Branson B;
JAMA Intern Med; 2017 Aug; 177(8):1083-1092. PubMed ID: 28628702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
